NEPHROS ($NEPH) posted quarterly earnings results for Q4 2025 on Thursday, March 12th. The company reported earnings of $0.01 per share, missing estimates of $0.01 by $0.00. The company also reported revenue of $4,730,000, beating estimates of $4,540,020 by $189,980.
You can see Quiver Quantitative's $NEPH stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
NEPHROS Hedge Fund Activity
We have seen 25 institutional investors add shares of NEPHROS stock to their portfolio, and 9 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC. added 69,149 shares (+inf%) to their portfolio in Q4 2025, for an estimated $337,447
- VANGUARD GROUP INC removed 47,662 shares (-16.9%) from their portfolio in Q4 2025, for an estimated $232,590
- MESIROW FINANCIAL INVESTMENT MANAGEMENT, INC. added 36,200 shares (+262.3%) to their portfolio in Q4 2025, for an estimated $176,656
- NAVELLIER & ASSOCIATES INC added 27,175 shares (+inf%) to their portfolio in Q4 2025, for an estimated $132,614
- DE LISLE PARTNERS LLP added 25,000 shares (+inf%) to their portfolio in Q4 2025, for an estimated $122,000
- QUADRATURE CAPITAL LTD added 23,004 shares (+inf%) to their portfolio in Q4 2025, for an estimated $112,259
- MARSHALL WACE, LLP added 21,983 shares (+inf%) to their portfolio in Q4 2025, for an estimated $107,277
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
